Fibrinogen survival with [75Se]Selenomethionine during L-asparaginase therapy.
D000230:Adenocarcinoma / Q000188:drug therapy; D000293:Adolescent; D000328:Adult; D000368:Aged; D001215:Asparaginase / Q000627:therapeutic use*; D001772:Blood Cell Count; D001792:Blood Platelets / Q000166:cytology; D005260:Female; D005340:Fibrinogen / Q000378:metabolism*; D006493:Heparin / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D008111:Liver Function Tests; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008297:Male; D008715:Methionine; D008875:Middle Aged; D011868:Radioisotopes; D012643:Selenium; D013917:Thrombin / Q000032:analysis
D011868:Radioisotopes; D005340:Fibrinogen; D006493:Heparin; D008715:Methionine; D013917:Thrombin; D001215:Asparaginase; D012643:Selenium